MoneyWorks4Me

Eris Lifesciences informs about board meeting

19 Nov 2025 Evaluate
Eris Lifesciences has informed that the meeting of the Board of Directors of the Company is scheduled on 24/11/2025 to consider and approve issuance of equity shares of the Company by way of a preferential issue for consideration other than cash.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1759.10
Dr. Reddys Labs. 1230.50
Cipla 1313.70
Lupin 1946.00
Zydus Lifesciences 1139.00
View more..